Hostname: page-component-848d4c4894-x24gv Total loading time: 0 Render date: 2024-05-12T13:28:52.532Z Has data issue: false hasContentIssue false

Clinical outcomes associated with blood-culture contamination are not affected by utilization of a rapid blood-culture identification system

Published online by Cambridge University Press:  20 March 2023

Sidra Liaquat Khan
Affiliation:
Department of Epidemiology, College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska
Gleb Haynatzki
Affiliation:
Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska
Sharon J. Medcalf
Affiliation:
Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska
Mark E. Rupp*
Affiliation:
Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska
*
Author for correspondence: Mark E. Rupp, E-mail: merupp@unmc.edu

Abstract

Objective:

Contaminated blood cultures result in extended hospital stays and extended durations of antibiotic therapy. Rapid molecular-based blood culture testing can speed positive culture detection and improve clinical outcomes, particularly when combined with an antimicrobial stewardship program. We investigated the impact of a multiplex polymerase chain reaction (PCR) FilmArray Blood Culture Identification (BCID) system on clinical outcomes associated with contaminated blood cultures.

Methods:

We conducted a retrospective cohort study involving secondary data analysis at a single institution. In this before-and-after study, patients with contaminated blood cultures in the period before PCR BCID was implemented (ie, the pre-PCR period; n = 305) were compared to patients with contaminated blood cultures during the period after PCR BCID was implemented (ie, the post-PCR implementation period; n = 464). The primary exposure was PCR status and the main outcomes of the study were length of hospital stay and days of antibiotic therapy.

Results:

We did not detect a significant difference in adjusted mean length of hospital stay before (10.8 days; 95% confidence interval [CI], 9.8–11.9) and after (11.2 days; 95% CI, 10.2–12.3) the implementation of the rapid BCID panel in patients with contaminated blood cultures (P = .413). Likewise, adjusted mean days of antibiotic therapy between patients in pre-PCR group (5.1 days; 95% CI, 4.5–5.7) did not significantly differ from patients in post-PCR group (5.3 days; 95% CI, 4.8–5.9; P = .543).

Conclusion:

The introduction of a rapid PCR-based blood culture identification system did not improve clinical outcomes, such as length of hospital stay and duration of antibiotic therapy, in patients with contaminated blood cultures.

Type
Original Article
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adrie, C, Garrouste-Orgeas, M, Ibn Essaied, W, et al. Attributable mortality of ICU-acquired bloodstream infections: impact of the source, causative micro-organism, resistance profile and antimicrobial therapy. J Infect 2017;74:131141.10.1016/j.jinf.2016.11.001CrossRefGoogle Scholar
Diekema, DJ, Beekmann, SE, Chapin, KC, Morel, KA, Munson, E, Doern, GV. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol 2003;41:36553660.10.1128/JCM.41.8.3655-3660.2003CrossRefGoogle Scholar
Bauer, KA, Perez, KK, Forrest, GN, Goff, DA. Review of rapid diagnostic tests used by antimicrobial stewardship programs. Clin Infect Dis 2014;59 suppl 3:S134S145.10.1093/cid/ciu547CrossRefGoogle Scholar
Opota, O, Croxatto, A, Prod’hom, G, Greub, G. Blood culture-based diagnosis of bacteraemia: state of the art. Clin Microbiol Infect 2015;21:313322.10.1016/j.cmi.2015.01.003CrossRefGoogle Scholar
Pien, BC, Sundaram, P, Raoof, N, et al. The clinical and prognostic importance of positive blood cultures in adults. Am J Med 2010;123:819828.10.1016/j.amjmed.2010.03.021CrossRefGoogle Scholar
Hall, KK, Lyman, JA. Updated review of blood culture contamination. Clin Microbiol Rev 2006;19:788802.10.1128/CMR.00062-05CrossRefGoogle Scholar
Doern, GV, Carroll, KC, Diekema, DJ, et al. Practical guidance for clinical microbiology laboratories: a comprehensive update on the problem of blood culture contamination and a discussion of methods for addressing the problem. Clin Microbiol Rev 2019;33:e0000919.10.1128/CMR.00009-19CrossRefGoogle Scholar
Klucher, JM, Davis, K, Lakkad, M, Painter, JT, Dare, RK. Risk factors and clinical outcomes associated with blood culture contamination. Infect Control Hosp Epidemiol 2022;43:291297.CrossRefGoogle ScholarPubMed
Gonzalez, MD, Chao, T, Pettengill, MA. Modern blood culture: management decisions and method options. Clin Lab Med 2020;40:379392.10.1016/j.cll.2020.07.001CrossRefGoogle Scholar
BioFire Diagnostics I, ed. FilmArray blood culture identification panel: instruction booklet. Salt Lake City, UT: BioFire Diagnostics; 2013.Google Scholar
Blaschke, AJ, Heyrend, C, Byington, CL, et al. Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagn Microbiol Infect Dis 2012;74:349355.10.1016/j.diagmicrobio.2012.08.013CrossRefGoogle Scholar
Buchan, BW, Ginocchio, CC, Manii, R, et al. Multiplex identification of gram-positive bacteria and resistance determinants directly from positive blood culture broths: evaluation of an automated microarray-based nucleic acid test. PLoS Med 2013;10:e1001478.10.1371/journal.pmed.1001478CrossRefGoogle Scholar
Ledeboer, NA, Lopansri, BK, Dhiman, N, et al. Identification of gram-negative bacteria and genetic resistance determinants from positive blood culture broths by use of the verigene gram-negative blood culture multiplex microarray-based molecular assay. J Clin Microbiol 2015;53:24602472.10.1128/JCM.00581-15CrossRefGoogle Scholar
Pence, MA, McElvania TeKippe E, Burnham CA. Diagnostic assays for identification of microorganisms and antimicrobial resistance determinants directly from positive blood culture broth. Clin Lab Med 2013;33:651684.10.1016/j.cll.2013.03.010CrossRefGoogle Scholar
Buehler, SS, Madison, B, Snyder, SR, et al. Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis. Clin Microbiol Rev 2016;29:59103.CrossRefGoogle ScholarPubMed
Pardo, J, Klinker, KP, Borgert, SJ, Butler, BM, Giglio, PG, Rand, KH. Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel. Diagn Microbiol Infect Dis 2016;84:159164.10.1016/j.diagmicrobio.2015.10.023CrossRefGoogle ScholarPubMed
MacVane, SH, Raux, BR, Smith, TT. Evaluation of rapid polymerase chain reaction-based organism identification of gram-positive cocci for patients with a single positive blood culture. Eur J Clin Microbiol Infect Dis 2019;38:14711479.CrossRefGoogle ScholarPubMed
Cattoir, V, Merabet, L, Djibo, N, et al. Clinical impact of a real-time PCR assay for rapid identification of Staphylococcus aureus and determination of methicillin resistance from positive blood cultures. Clin Microbiol Infect 2011;17:425431.10.1111/j.1469-0691.2010.03233.xCrossRefGoogle Scholar
Faul, F, Erdfelder, E, Lang, AG, Buchner, A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175191.10.3758/BF03193146CrossRefGoogle Scholar
MacVane, SH, Nolte, FS. Benefits of adding a rapid PCR-based blood culture identification panel to an established antimicrobial stewardship program. J Clin Microbiol 2016;54:24552463.10.1128/JCM.00996-16CrossRefGoogle Scholar
Sidhu, SK, Malhotra, S, Devi, P, Tuli, AK. Significance of coagulase-negative Staphylococcus from blood cultures: persisting problems and partial progress in resource-constrained settings. Iran J Microbiol 2016;8:366371.Google Scholar
Donner, LM, Campbell, WS, Lyden, E, Van Schooneveld, TC. Assessment of rapid blood-culture identification result interpretation and antibiotic prescribing practices. J Clin Microbiol 2017;55:14961507.10.1128/JCM.02395-16CrossRefGoogle Scholar
Barrasa-Villar, JI, Aibar-Remón, C, Prieto-Andrés, P, Mareca-Doñate, R, Moliner-Lahoz, J. Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms. Clin Infect Dis 2017;65:644652.10.1093/cid/cix411CrossRefGoogle Scholar
Vernaz, N, Hill, K, Leggeat, S, et al. Temporal effects of antibiotic use and Clostridium difficile infections. J Antimicrob Chemother 2009;63:12721275.10.1093/jac/dkp128CrossRefGoogle Scholar
Dellit, TH, Owens, RC, McGowan, JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159177.10.1086/510393CrossRefGoogle Scholar
Banerjee, R, Teng, CB, Cunningham, SA, et al. Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis 2015;61:10711080.10.1093/cid/civ447CrossRefGoogle ScholarPubMed
Nebraska Medicine Antimicrobial Stewardship Program. Recommendations regarding the use of Blood Culture Identification (BCID) panel data. https://www.unmc.edu/intmed/_documents/id/asp/news/bcid2-final-8-11-21.pdf. Published August 11, 2021. Updated 2021. Accessed December 17, 2022.Google Scholar
Supplementary material: File

Khan et al. supplementary material

Khan et al. supplementary material

Download Khan et al. supplementary material(File)
File 13.2 KB